CHARACTERIZATION OF A NOVEL G PROTEIN IN HUMAN PLATELETS
人类血小板中新型 G 蛋白的表征
基本信息
- 批准号:3364142
- 负责人:
- 金额:$ 26.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1990
- 资助国家:美国
- 起止时间:1990-07-01 至 1995-06-30
- 项目状态:已结题
- 来源:
- 关键词:G protein antibody cell membrane electrofocusing electron microscopy genetic library human subject human tissue immunofluorescence technique immunoprecipitation insect poison laboratory rabbit megakaryocytes molecular cloning monomer pertussis toxin phorbols phospholipase A2 phospholipase C phosphorylation platelet activation platelets polymerase chain reaction posttranslational modifications protein kinase C protein sequence protein structure function receptor second messengers stoichiometry terpene saponin thrombin tissue /cell culture western blottings
项目摘要
This proposal will examine the structure and function of a 40 kDa protein
in platelets which we believe to be the alpha subunit of a guanine
nucleotide-binding regulatory protein or G protein. Based upon our recent
studies, this protein has several novel properties. First, it is
phosphorylated during platelet activation, apparently by protein kinase C.
Second, it is immunologically cross-reactive with G(z-alpha), a putative
alpha subunit that has been cloned from two non-platelet cDNA libraries,
but not yet isolated. Third, in contrast to the other G proteins which have
been a focus for platelet research, it is neither ADP-ribosylated by
pertussis toxin nor recognized by antisera that are specific for known
pertussis toxin-sensitive G proteins, such as G(i-alpha). Even though G(z-
alpha) is not known to be a substrate for protein kinase C, we have
provisionally named the platelet protein "G(z-alpha)(plt)" in
acknowledgement of the immunologic cross-reactivity of the two proteins.
The goal of our studies will be to understand the structure and biology of
G(z-alpha)(plt). Specifically, we will: (1) determine the identity of G(z-
alpha)(plt) and define its relationship to G(z-alpha), (2) identify the
sites at which G(z-alpha)(plt) is phosphorylated, (3) determine the
biochemical consequences of phosphorylation and (4) define the role of G(z-
alpha)(plt) in platelet function.
该提案将研究40 kDa蛋白质的结构和功能
我们认为血小板是鸟嘌呤的α亚单位
核苷酸结合调节蛋白或G蛋白。根据我们最近的
研究表明,这种蛋白质具有几种新的特性。一是
在血小板活化过程中磷酸化,显然是通过蛋白激酶C。
其次,它与G(z-alpha)具有免疫交叉反应性,
从两个非血小板cDNA文库中克隆的α亚基,
但还没有被隔离。第三,与其他G蛋白相比,
它一直是血小板研究的焦点,它既不是ADP-核糖基化的,也不是ADP-核糖基化的。
百日咳毒素也不被已知的百日咳毒素特异性的抗血清识别,
百日咳毒素敏感的G蛋白,如G(i-α)。即使G(z-
α)是蛋白激酶C的底物,我们有
在1999年,
确认两种蛋白质的免疫交叉反应性。
我们研究的目标是了解
G(z-alpha)(plt)。具体地说,我们将:(1)确定G(z-1)的恒等式。
α)(plt),并定义其与G(z-alpha)的关系,(2)确定
G(z-alpha)(plt)被磷酸化的位点,(3)确定
磷酸化的生化后果和(4)定义G(z-)的作用,
α)(PLT)的血小板功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LAWRENCE F BRASS其他文献
LAWRENCE F BRASS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LAWRENCE F BRASS', 18)}}的其他基金
Studies of Physiologic and Pathologic Platelet Plug Formation
生理和病理血小板栓子形成的研究
- 批准号:
10161819 - 财政年份:2020
- 资助金额:
$ 26.6万 - 项目类别:
Studies of Physiologic and Pathologic Platelet Plug Formation
生理和病理血小板栓子形成的研究
- 批准号:
10656284 - 财政年份:2020
- 资助金额:
$ 26.6万 - 项目类别:
Studies of Physiologic and Pathologic Platelet Plug Formation
生理和病理血小板栓子形成的研究
- 批准号:
10434806 - 财政年份:2020
- 资助金额:
$ 26.6万 - 项目类别:
Regulation of the early events of platelet activation
血小板活化早期事件的调节
- 批准号:
8456213 - 财政年份:2010
- 资助金额:
$ 26.6万 - 项目类别:
Regulation of the early events of platelet activation
血小板活化早期事件的调节
- 批准号:
8242745 - 财政年份:2010
- 资助金额:
$ 26.6万 - 项目类别:
Regulation of the early events of platelet activation
血小板活化早期事件的调节
- 批准号:
7888575 - 财政年份:2010
- 资助金额:
$ 26.6万 - 项目类别:
相似海外基金
Development of B cell functional studies on primary antibody deficiencies
一抗缺陷 B 细胞功能研究的进展
- 批准号:
502607 - 财政年份:2024
- 资助金额:
$ 26.6万 - 项目类别:
Thymus antibody-secreting cells: major players in autoimmunity.
胸腺抗体分泌细胞:自身免疫的主要参与者。
- 批准号:
502578 - 财政年份:2024
- 资助金额:
$ 26.6万 - 项目类别:
ICF: AbVax Combination vaccination and broadly neutralising antibody therapy in HIV to induce a protective Tcell vaccinal effect, a mechanistic study
ICF:AbVax 联合疫苗接种和广泛中和 HIV 抗体疗法诱导保护性 T 细胞疫苗效应,一项机制研究
- 批准号:
MR/Y008847/1 - 财政年份:2024
- 资助金额:
$ 26.6万 - 项目类别:
Research Grant
Enabling The Targeted Delivery Of DNA G-quadruplex Ligands using a Novel Antibody DAR-1 Platform
使用新型抗体 DAR-1 平台实现 DNA G 四链体配体的靶向递送
- 批准号:
BB/Y002180/1 - 财政年份:2024
- 资助金额:
$ 26.6万 - 项目类别:
Research Grant
Antibody-Palladium Conjugates for Bioorthogonal Anti-Cancer Prodrug Activation
用于生物正交抗癌前药激活的抗体-钯缀合物
- 批准号:
EP/Y024540/1 - 财政年份:2024
- 资助金额:
$ 26.6万 - 项目类别:
Fellowship
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:
24K19237 - 财政年份:2024
- 资助金额:
$ 26.6万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
A Semi-Automated Antibody-Discovery Platform to Target Challenging Biomolecules
针对具有挑战性的生物分子的半自动化抗体发现平台
- 批准号:
MR/Y003616/1 - 财政年份:2024
- 资助金额:
$ 26.6万 - 项目类别:
Fellowship
Monitoring antibody protection against SARS-CoV-2 variants
监测抗体对 SARS-CoV-2 变体的保护作用
- 批准号:
MR/Y033698/1 - 财政年份:2024
- 资助金额:
$ 26.6万 - 项目类别:
Research Grant
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
- 批准号:
479128 - 财政年份:2023
- 资助金额:
$ 26.6万 - 项目类别:
Operating Grants
Pharmacokinetic analysis of antibody drug conjugate in tumor cells utilizing synchrotron soft X-ray imaging
利用同步加速器软 X 射线成像对肿瘤细胞中抗体药物偶联物进行药代动力学分析
- 批准号:
23H03716 - 财政年份:2023
- 资助金额:
$ 26.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)